H. Lee Moffitt Cancer Center and Research Institute: all 539 studies

Page 3 of 6. Open to participants first (74), then studies with results posted, then the rest; newest registration first within each.

• Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine in Combination With Stereotactic RadiosurgeryTerminatedNCT00833859Phase 2Results posted
• Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML)CompletedNCT00831766Phase 1/2Results posted
• A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer CachexiaCompletedNCT00815685Not applicableResults posted
• Graft-Versus-Host Disease (GVHD) Prophylaxis After Allogeneic Peripheral Blood Hematopoietic Cell TransplantationCompletedNCT00803010Phase 2Results posted
• Autologous SCT Followed by Dendritic Cell p53 Vaccination in Patients With Limited Stage Small Cell Lung CancerTerminatedNCT00776295Phase 2Results posted
• Merits of Performing a Modified Template Retroperitoneal Lymph Node DissectionCompletedNCT00751140Not applicableResults posted
• Cyclophosphamide, VELCADE, DOXIL, and Dexamethasone, (CVDD) in Newly Diagnosed Patients With Multiple Myeloma (MM)CompletedNCT00750815Phase 1/2Results posted
• Varenicline Effects on Cue Reactivity and Smoking Reward/ReinforcementCompletedNCT00747643Not applicableResults posted
• Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell TransplantationTerminatedNCT00720629Phase 2Results posted
• Genomic Directed Salvage Chemotherapy With Either Liposomal Doxorubicin Or TopotecanTerminatedNCT00720096Not applicableResults posted
• PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive TreatmentCompletedNCT00694551Not applicableResults posted
• Cetuximab Plus Conformal Thoracic Radiotherapy in Patients (Pts) With Inoperable or Unresectable Locally Advanced Non-Small Cell Lung Cancer (LA - NSCLC)CompletedNCT00673738Phase 2Results posted
• Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid NeoplasmsCompletedNCT00665002Not applicableResults posted
• Pre-Transplant 5-Azacitidine In Patients With High-Risk Myelodysplastic Syndrome Who Are Candidates For Allogeneic Hematopoietic Cell TransplantCompletedNCT00660400Not applicableResults posted
• Study of Oral Dasatinib in Subjects With Myelodysplastic Syndrome (MDS) and Excess Marrow BlastsCompletedNCT00624585Not applicableResults posted
• Pegylated Liposomal Doxorubicin, Low Freq Dexamethasone & Revlimid (Dd-R) in Newly Diagnosed Multiple Myeloma (MM)CompletedNCT00617591Phase 2Results posted
• To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic AcidCompletedNCT00617409Phase 2Results posted
• Pemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant ChemTerminatedNCT00612677Phase 2Results posted
• Lenalidomide in Comb w/Rituximab for Pts w/CD5+/CD20+ Hem Malignancies Who Relapse/Progress After RituximabCompletedNCT00609869Phase 2Results posted
• Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine TumorsTerminatedNCT00609765Phase 2Results posted
• A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and GlioblastomaCompletedNCT00606008Phase 2Results posted
• Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With Malignant Pleural Mesothelioma (MPM)TerminatedNCT00604461Phase 1/2Results posted
• Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung CancerCompletedNCT00601796Phase 2Results posted
• Phase II Trial Of ZK-EPO (ZK 219477) (Sagopilone) In Metastatic MelanomaCompletedNCT00598507Phase 2Results posted
• A Phase I/II Study of Dasatinib and DacarbazineCompletedNCT00597038Phase 1/2Results posted
• Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial NeoplasiaCompletedNCT00596011Phase 2Results posted
• Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum CarcinomaCompletedNCT00504257Phase 2Results posted
• Phase III of RRM1 & ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLCCompletedNCT00499109Phase 3Results posted
• Phase II Trial of Pentostatin and Targeted BusulfanCompletedNCT00496340Phase 2Results posted
• Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC)TerminatedNCT00495625Phase 2Results posted
• Phase II Study of Sunitinib Malate Following Hepatic Artery EmbolizationCompletedNCT00434109Phase 2Results posted
• Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue SarcomaCompletedNCT00400569Phase 2Results posted
• Maintenance Azacitidine in Elderly Patients With Acute Myeloid Leukemia (AML) in CR After Induction ChemotherapyCompletedNCT00387647Phase 2Results posted
• External Beam Radiation With Intratumoral Injection of Dendritic Cells As Neo-Adjuvant Treatment for SarcomaCompletedNCT00365872Phase 2Results posted
• Phase II Trial of SAHA & Tamoxifen for Patients With Breast CancerCompletedNCT00365599Phase 2Results posted
• Busulfan Monotherapy as Conditioning for Autologous Hematopoietic Progenitor Cell TransplantationTerminatedNCT00363467Not applicableResults posted
• Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)CompletedNCT00361140Phase 4Results posted
• Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and OligodendrogliomasTerminatedNCT00360828Phase 2Results posted
• Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTXCompletedNCT00360685Not applicableResults posted
• Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients With Non-Small Cell Lung CancerTerminatedNCT00351039Phase 1/2Results posted
• Study of Melphalan and Topotecan (MT) Followed by Autologous Stem Cell Rescue in Patients With Multiple Myeloma.CompletedNCT00325416Phase 1/2Results posted
• Bortezomib Followed by High-Dose Melphalan and Bortezomib as Conditioning Regimen for Tandem Stem Cell TransplantsCompletedNCT00307086Phase 2Results posted
• Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung CancerCompletedNCT00231465Phase 2Results posted
• Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLCCompletedNCT00226590Phase 2Results posted
• Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cell Lung Cancer.CompletedNCT00226577Phase 2Results posted
• Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD)TerminatedNCT00215943Phase 3Results posted
• The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung CancerCompletedNCT00215930Phase 2Results posted
• Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A)TerminatedNCT00127036Phase 2Results posted
• Neoadjuvant IRESSA As Single Agent PreopTherapy for NSCLC With Molecular CorrelatesTerminatedNCT00104728Not applicableResults posted
• Universal Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)-Producing and CD40L Expressing Bystander Cell Line for Tumor Vaccine in MelanomaCompletedNCT00101166Phase 2Results posted
• Universal Granulocyte Macrophage-colony Stimulating Factor (GM-CSF)-Producing and GM.CD40L for Autologous Tumor Vaccine in Mantle Cell LymphomaCompletedNCT00101101Phase 2Results posted
• ProSalud in Latinos Living in Rural/Agricultural Communities Within Moffitt's Catchment AreaActive, not recruitingNCT07218848Not applicable
• Compare Airway Pressure Release Ventilation (APRV) to Conventional Mechanical VentilaWithdrawnNCT07111039Not applicable
• Breast Cancer Survivors RESET (Reducing Weight and Elevated Stress Levels Using Educational and Behavioral Tools): A Pilot, Feasibility StudyCompletedNCT07101861Not applicable
• NutritiOUs fRuIts and veggieS to Improve Health: A Culinary Medicine InterventionCompletedNCT06926972Not applicable
• Creation of an Infrastructure to Support Delivery of mHealth Interventions for Cancer PatientsCompletedNCT06909357Not applicable
• Study of Adaptive Immunotherapy With VEGFR-TKI in Patients With Advanced RCCSuspendedNCT06860386Phase 2
• Phase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing Surgery for HNSCCActive, not recruitingNCT06855212Phase 2
• Exploring Men s Prostate Cancer Genetic Risk PerceptionsCompletedNCT06764992
• Adaptive Androgen Deprivation and Docetaxel in Metastatic Castration Sensitive Prostate CancerActive, not recruitingNCT06734130Phase 2
• Physical Activity and Nutrition to Halt Elevated Risk in the Pancreas Interception CenterActive, not recruitingNCT06712797Not applicable
• Immunologic Targeting of ESR1 Receptor for Hormone Receptor Expressing Metastatic Breast CancerActive, not recruitingNCT06691035Phase 1
• Investigation of MP Pollution in the Human Respiratory System and Its Relationship to Lung CancerActive, not recruitingNCT06530615
• Study of IPMN Progression Prevention With Tocotrienol (SIPP-T3)Active, not recruitingNCT06519097Phase 2
• Study to Assess Xevinapant in Preoperative Subjects With Recurrent High-Grade Glioma (rHGG)WithdrawnNCT06463184Phase 1
• Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic CancerCompletedNCT06378047Phase 1
• High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED Trial)Active, not recruitingNCT06337552Not applicable
• Cancer Coaching and Remote Education for Self-Empowerment (CARES) StudyCompletedNCT06323291Early Phase 1
• Study of CG0070 After Transurethral Resection in Patients With IR NMIBCActive, not recruitingNCT06253845Phase 1
• TBio-4101 and Pembro wi/ or w/o Chemo in Recurrent/Metastatic HNSCCCompletedNCT06236425Phase 1
• Phototherapy and Mogamulizumab in Early Stage MF (PLIGHT)SuspendedNCT06235281Early Phase 1
• Targeting ODC as an Immunotherapeutic Target in STK11 (LKB1) Pathway-Deficient NSCLC (DFMO)SuspendedNCT06219174Phase 1/2
• REFLECT: Reproductive Education and Fertility Links for Cancer TreatmentActive, not recruitingNCT06199726
• Non-Invasive Biomarkers in Prostate Cancer Disease ManagementSuspendedNCT06144619
• Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal CancerActive, not recruitingNCT06109467Phase 2
• App for Reducing Cravings to SmokeActive, not recruitingNCT06088498Phase 2
• The MONITOR Study: Remote Monitoring Of a Nutrition Intervention To Optimize Treatment ResponseCompletedNCT06050395Not applicable
• Enhancing Cancer Survivorship With PickleballCompletedNCT06048822Not applicable
• Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS)Active, not recruitingNCT06001268Not applicable
• Senior Adult Hepatobiliary Prehab StudyActive, not recruitingNCT05921552Not applicable
• Genomically Guided Radiation Dose Personalization in Locally Advanced NSCLCCompletedNCT05873439Early Phase 1
• A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)Active, not recruitingNCT05809752Phase 1
• The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr SurvivorsCompletedNCT05798780Not applicable
• Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBCActive, not recruitingNCT05768347Phase 1
• Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell ImmunotherapyCompletedNCT05763563Not applicable
• Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate CancerActive, not recruitingNCT05751941Phase 2
• Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN NeoplasmsActive, not recruitingNCT05732961Phase 2
• Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain MetastasesCompletedNCT05704933Early Phase 1
• Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor MalignanciesCompletedNCT05694364Phase 1
• The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel TherapeuticsActive, not recruitingNCT05692596
• Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority PopulationsActive, not recruitingNCT05687188
• HPV Multilevel Intervention Strategies Targeting Immunization in Community Settings (HPV MISTICS)SuspendedNCT05677360Not applicable
• Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Pancreatic Cancer PatientsCompletedNCT05675059Not applicable
• Remote Resistance Exercise Powering Survivors - Gastrointestinal OncologyCompletedNCT05664178Phase 1/2
• STRONG Program for Cancer PatientsCompletedNCT05649969Not applicable
• Enhancing Long-Term Smoking Abstinence Among Cervical Cancer Survivors (Project ACCESS)Active, not recruitingNCT05645146Not applicable
• Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory MelanomaCompletedNCT05628883Phase 1
• Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination ImmunotherapyCompletedNCT05579847
• Olaparib in Combination With Pembrolizumab for Advanced Uveal MelanomaActive, not recruitingNCT05524935Phase 2
• Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Gastroesophageal Cancer (GEC) PatientsCompletedNCT05438940Not applicable

← H. Lee Moffitt Cancer Center and Research Institute overview and focus areas